The Biotech Startups Podcast with guest Alok Tayi, Founder & CEO of Vibe Bio

The biotech startups podcast episode art.

Watch the 3 part podcast episode on YouTube! We are proud to share a recent The Biotech Startups Podcast episode hosted by Jon Chee, CEO of Excedr. In the episode, Jon and Alok discuss the many opportunities that can improve the biotech industry and how Vibe Bio is tackling the problem of funding & guiding […]

STAT – Upending drug industry financing

Allison DeAngelis authored an article, featuring Vibe Bio CEO, Alok Tayi, on ‘decentralized science’ which seeks to upend drug industry financing. The article detailed Alok’s journey to founding Vibe Bio. “The experience stuck with Tayi, who is a scientist and entrepreneur, and led him to co-found a new organization that’s designed to allow patients, scientists, […]

Forbes – Alok Tayi’s new start-up is putting drug development into patients’ hands

John Cumbers authored an article featuring Alok Tayi’s new start-up, Vibe Bio. “In short, the contours of drug development are defined around inflection points — the kinds of milestones that serve as “power-ups” to move a company to the next level of funding and scientific research by increasing a company’s valuation and strategically informing what […]

Coindesk – How Vibe Bio plans to retool biotech funding

David Z. Morris authored an article on Decentralized Autonomous Organizations for funding research for diseases. In the article, our founder and CEO, Alok Tayi, explains how a decentralized science approach can accelerate biotech funding opportunities. “The obstacle for all of us was that there wasn’t the funding to advance research. The challenge in finding a […]

The Scoop – A conversation with Alok Tayi

The Scoop Podcast episode art for A conversation with Alok Tayi.

Episode 58 of Season 4 of The Scoop was recorded remotely with The Block’s Frank Chaparro and Alok Tayi, Co-Founder & CEO of Vibe Bio. “In this episode of The Scoop, Tayi shares his vision for how Vibe Bio aims to disrupt the centralized control of big pharma” You can read a full summary and […]